How Catalent’s integrated and innovative model can help to ensure timely and optimal clinical supply execution in the APAC region.

Learn ways that clinical supply strategies for late phase vary from early phase.

Strategies sponsors can enable with a supply partner in order to minimize project risk.

Cultural considerations when planning and implementing an APAC clinical supply strategy.

Summary: FastChain® demand led supply is a continuous GMP approach to secondary packaging, label printing and application, release, and regional distribution of patient kits to clinical sites based upon actual patient and site need. The FastChain® approach will...

Summary: Integrated approach from development to clinical and benefits of working with a single integrated provider.

Summary: Utilizing an integrated solution with a single provider can help ensure a smooth transition from Phase 1 into Phase 2.

Summary: As the clinical development market evolves rapidly in China, a rising number of multi-national companies are initiating early phase clinical trials in China in parallel with other sponsor countries.

Summary: View this exclusive webcast specifically designed for pharmaceutical & biotech consultants and early stage development partners. Hear three early drug development industry experts present...

Summary: Discover what challenges can occur in Phase 3 and how to address them in advance to limit potential setbacks.